Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Statement re: State Announcements

28 Apr 2021 07:00

RNS Number : 7946W
Indivior PLC
28 April 2021
 

Statement re: State Announcements

 

In response to various States Attorney General's recent announcements regarding SUBOXONE® (buprenorphine and naloxone ) Film settlements, Indivior made the following statement:

 

· The various state settlement agreements being announced this week are administrative in nature, and simply formalize the individual state settlements which were previously agreed to in principle as part of the July 2020 criminal and civil resolution between Indivior and the states (and the federal government). As such, there is no new financial or legal obligation that has arisen. The Company was pleased to put those issues behind it in 2020 and remains focused on realizing its patient-focused Vision and fulfilling its compliance commitments.

 

The Company will have no further comment on this matter.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFDLLLFZLLBBL
Date   Source Headline
15th Oct 20247:00 amRNSNotice of Results
15th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 202412:00 pmRNSPreliminary Q3 Results & Updated FY 2024 Guidance
8th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20242:30 pmRNSChair Succession Plan
1st Oct 20247:58 amRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSIndivior Provides Update on AEF0117
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20249:00 amRNSTotal Voting Rights
27th Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSIndivior to Participate in Upcoming Events
14th Aug 20247:36 amRNSHolding(s) in Company
13th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSCompletion of Share Repurchase Program
6th Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20248:24 amRNSTotal Voting Rights
30th Jul 20242:31 pmRNSBlock Listings of Shares
30th Jul 20242:18 pmRNSDirector/PDMR Shareholding
30th Jul 20242:16 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20242:40 pmRNSDirector/PDMR Shareholding
29th Jul 20242:36 pmRNSDirector/PDMR Shareholding
29th Jul 20242:17 pmRNSDirector/PDMR Shareholding
29th Jul 20242:15 pmRNSDirector/PDMR Shareholding
26th Jul 20243:37 pmRNSDirector/PDMR Shareholding
26th Jul 20243:34 pmRNSDirector/PDMR Shareholding
25th Jul 20247:10 amRNSShare Repurchase Program
25th Jul 20247:00 amRNSHalf-year Report
23rd Jul 20247:00 amRNSTransaction in Own Shares
18th Jul 20244:26 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSNotice of Results
12th Jul 20247:00 amRNSHolding(s) in Company
11th Jul 20247:00 amRNSHolding(s) in Company
9th Jul 20247:00 amRNSIndivior Provides Business Update
9th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20243:39 pmRNSHolding(s) in Company
3rd Jul 20241:56 pmRNSHolding(s) in Company
1st Jul 20249:44 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 202410:54 amRNSHolding(s) in Company
28th Jun 202410:32 amRNSHolding(s) in Company
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20248:06 amRNSTransition to U.S. Primary Listing Complete

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.